Accessibility Menu
Tetratherix logo

Tetratherix(ASX) TTX

Market CapA$376.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2025)+135%
5 YearN/A
1 Year+60%
1 Month+0%
A$6.68
+2.77%
+0.18Today
Tetratherix last closing stock price
MetricPriceDate
Last closeAUD 6.502026-08-13
Tetratherix stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-13.79%AUD 7.542026-08-06
1 month+0%AUD 6.502026-07-14
3 month+30%AUD 5.002026-05-15
Year to date+98.17%AUD 3.282025-12-30
1 year+60.49%AUD 4.052025-08-13
Since inception+135.1%AUD 3.022025-06-30

Tetratherix Financials at a Glance

Market Cap

A$376.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

-A$0.24

P/E Ratio

-29.87

Dividend

A$0.00

Beta (Volatility)

0.47 (Low)

Price

A$6.68

Volume

1,378

Open

A$6.72

Previous Close

A$6.50

Daily Range

A$6.68 - A$6.88

52-Week Range

A$3.09 - A$8.08

Estimated Earnings Date

Aug 27, 2026

TTX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tetratherix

Tetratherix Ltd. is a pioneering company in the biomaterials and regenerative medicine sectors, established in 2015 and headquartered in Alexandria, Australia. The company focuses on developing innovative products using its proprietary Tetramatrix platform technology, targeting applications in bone regeneration, tissue spacing, and advanced tissue healing.

Products and Services
  • Bone regeneration solutions utilizing Tetramatrix technology
  • Tissue spacing products for enhanced surgical outcomes
  • Advanced tissue healing applications for improved recovery
Growth Outlook
  • Strong market demand for regenerative medicine solutions is increasing
  • Expansion into international markets is underway
  • Innovative product pipeline expected to drive future revenue growth
Financial Highlights
  • Market capitalization stands at approximately AUD 358 million
  • Stock price has ranged from AUD 3.09 to AUD 7.50 in the past year
  • Recent trading volume indicates growing investor interest
Tetratherix Ltd. operates in a dynamic industry with significant growth potential. The company's focus on innovative biomaterials positions it well to capitalize on the increasing demand for regenerative medicine solutions. With a solid market capitalization and a strong product pipeline, Tetratherix is poised for future expansion both domestically and internationally. The recent stock price performance reflects investor confidence, suggesting a positive outlook for the company's continued development and market presence.
AI Generated • Jul 21, 2026

Industry

Biotechnology

Sector

Health Care

CEO

Will Knox

Website

tetratherix.com

Headquarters

Alexandria, NSW 2015, AU

TTX Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-150.03%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-3.35%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

A$376.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

53.04M

Volume

1.38K

Avg. Volume

22.49K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Tetratherix Performance Analysis

Tetratherix annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 239,448N/A
20232023-06-30AUD 0N/A
20242024-06-30AUD 33,956N/A
20252025-06-30AUD 0N/A
Tetratherix annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.03N/A
20232023-06-30AUD -0.0418.7%
20242024-06-30AUD -0.0540.1%
20252025-06-30AUD -0.19269.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

A$376.56MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AVH.AXAVITA Medical, Inc.
A$2.20-3.51%
MVF.AXMonash IVF Group Limited
A$0.70-0.00%
PEB.AXPacific Edge Limited
A$0.22+0.00%
SDI.AXSDI Limited
A$1.40+0.14%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About TTX

What is the current price of Tetratherix?

Tetratherix is trading at A$6.68 per share.

What is the 52-week range for Tetratherix?

Over the past 52 weeks, Tetratherix has traded between A$3.09 and A$8.08.

How much debt does Tetratherix have?

As of the most recent reporting period, Tetratherix reported total debt of A$2.04M.

How much cash does Tetratherix have on hand?

Tetratherix reported A$29.34M in cash and cash equivalents in its most recent financial results.

What is Tetratherix’s dividend yield?

Tetratherix does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services